Literature DB >> 25107349

Compensatory role of double mutation N348I/M184V on nevirapine binding landscape: insight from molecular dynamics simulation.

Wilson Karubiu1, Soumendranath Bhakat, Mahmoud E S Soliman.   

Abstract

Non-nucleoside reverse transcriptase inhibitors (NNRTI) have emerged as gold standards in current anti-AIDS drug discovery and development by allosterically inhibiting HIV reverse transcriptase (HIV-RT). Connection sub-domain mutation, N348I and the M184V active site mutation decreases HIV-1 RT susceptibility to NNRTI, nevirapine (NVP), whereas concurrence of both mutations improves enzyme susceptibility to NVP. Molecular dynamics simulation and enhanced post-dynamics analyses were applied to gain molecular insight into occurrence of N348I, M184V and N348I/M184V double mutations and their effect on NVP binding landscape. Results showed that the presence of the double mutation (N348I/M184V) ameliorates the drastic effects of connection sub-domain mutation, N348I alone on NVP binding, which correlates with experimental findings. We showed that the binding of NVP to the NNRTI binding pocket (NNIBP) is drastically distorted in the presence of connection sub-domain mutation, N348I and may further explain the impaired motions of mutant RTs compared to the wild type. The residue based fluctuation further suggested that the occurrence of N348I decreased the overall flexibility of NVP-HIV-RT complex whereas concurrence of N348I/M184V double mutation restored the conformational flexibility as compared to single mutant. This phenomenon was further validated by the trends of binding free energy as well as the per-residue footprints which showed an increased ∆Gbind in case of N348I/M184V double mutant as compared to N348I variant. Further, for the first time residue interaction network highlighted the structural changes due to occurrence of M184V and N348I mutations which gives a conclusive evidence of these mutations. This work provides the most comprehensive analysis of NVP resistance and the impact of double (N348I/M184V) mutation to date from a dynamics perspective and provides information that should prove useful for understanding the drug resistance mechanism against NVP. The results also provide preliminary data which might prove useful for the design of novel inhibitors that are less susceptible to drug resistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25107349     DOI: 10.1007/s10930-014-9576-8

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  35 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.

Authors:  Viktor von Wyl; Maryam Ehteshami; Jori Symons; Philippe Bürgisser; Monique Nijhuis; Lisa M Demeter; Sabine Yerly; Jürg Böni; Thomas Klimkait; Rob Schuurman; Bruno Ledergerber; Matthias Götte; Huldrych F Günthard
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

Review 4.  Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases.

Authors:  Stefan G Sarafianos; Kalyan Das; Stephen H Hughes; Eddy Arnold
Journal:  Curr Opin Struct Biol       Date:  2004-12       Impact factor: 6.809

5.  Comparison of MM/GBSA calculations based on explicit and implicit solvent simulations.

Authors:  Frithjof Godschalk; Samuel Genheden; Pär Söderhjelm; Ulf Ryde
Journal:  Phys Chem Chem Phys       Date:  2013-04-18       Impact factor: 3.676

6.  Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.

Authors:  Adele L McCormick; Chris M Parry; Anne Crombe; Ruth L Goodall; Ravindra K Gupta; Pontiano Kaleebu; Cissy Kityo; Michael Chirara; Greg J Towers; Deenan Pillay
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

7.  Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors.

Authors:  Atsuko Hachiya; Eiichi N Kodama; Stefan G Sarafianos; Matthew M Schuckmann; Yasuko Sakagami; Masao Matsuoka; Masafumi Takiguchi; Hiroyuki Gatanaga; Shinichi Oka
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

9.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born.

Authors:  Andreas W Götz; Mark J Williamson; Dong Xu; Duncan Poole; Scott Le Grand; Ross C Walker
Journal:  J Chem Theory Comput       Date:  2012-03-26       Impact factor: 6.006

View more
  1 in total

1.  Structural Characterizations of the Fas Receptor and the Fas-Associated Protein with Death Domain Interactions.

Authors:  Urmi Roy
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.